Conjunctival Lesion in a Patient With Ocular Graft-vs-Host Disease

JAMA Ophthalmol. 2017 Aug 1;135(8):883-884. doi: 10.1001/jamaophthalmol.2016.5483.

Authors

Grace L Paley¹, Asim V Farooq², Anthony J Lubniewski¹

Affiliations

¹ Department of Ophthalmology and Visual Sciences, Washington University in St Louis, St Louis, Missouri.
² Department of Ophthalmology and Visual Science, University of Chicago, Chicago, Illinois.

PMID: 28494062
DOI: 10.1001/jamaophthalmol.2016.5483

No abstract available

Publication types

Case Reports

MeSH terms

Aged
Antineoplastic Agents / therapeutic use
Bone Marrow Transplantation / adverse effects*
Carcinoma, Squamous Cell / diagnosis
Carcinoma, Squamous Cell / etiology*
Carcinoma, Squamous Cell / therapy
Combined Modality Therapy
Conjunctival Neoplasms / diagnosis
Conjunctival Neoplasms / etiology*
Conjunctival Neoplasms / therapy
Cryotherapy
Graft vs Host Disease / drug therapy
Graft vs Host Disease / etiology*
Humans
Immunosuppressive Agents / therapeutic use
Interferon alpha-2 / therapeutic use
Leukemia, Lymphocytic, Chronic, B-Cell / pathology
Leukemia, Lymphocytic, Chronic, B-Cell / therapy
Male
Tacrolimus / therapeutic use
Transplantation, Homologous

Substances

Antineoplastic Agents
Immunosuppressive Agents
Interferon alpha-2
Tacrolimus